Company Filing History:
Years Active: 2009-2011
Title: Innovations in Tumor Imaging by Jonathan McConathy
Introduction
Jonathan McConathy is an accomplished inventor based in Decatur, GA (US). He has made significant contributions to the field of medical imaging, particularly in the detection and evaluation of tumors. With a total of 2 patents to his name, McConathy's work is paving the way for advancements in cancer diagnostics.
Latest Patents
One of McConathy's latest patents focuses on tumor imaging compounds. This invention provides novel amino acid compounds that are instrumental in detecting and evaluating brain and body tumors. These compounds leverage the advantageous properties of α-aminoisobutyric acid (AIB) analogs, which are known for their rapid uptake and prolonged retention in tumors. Additionally, the compounds incorporate halogen substituents, including useful halogen isotopes such as fluorine-18, iodine-123, iodine-124, iodine-125, iodine-131, bromine-75, bromine-76, bromine-77, bromine-82, astatine-210, astatine-211, and other astatine isotopes. Furthermore, these compounds can be labeled with technetium and rhenium isotopes using established chelation complexes. The amino acid compounds disclosed have a high specificity for target sites when administered to a subject in vivo. The labeled amino acid compounds serve as effective imaging agents for detecting and monitoring tumors through Positron Emission Tomography (PET) and Single Photon Emission Computer Tomography (SPECT).
Career Highlights
Jonathan McConathy is affiliated with Emory University, where he continues to engage in innovative research. His work has garnered attention for its potential to improve cancer detection methods, ultimately benefiting patient outcomes.
Collaborations
McConathy collaborates with Mark M Goodman, further enhancing the research and development of tumor imaging technologies.
Conclusion
Jonathan McConathy's contributions to tumor imaging represent a significant advancement in medical diagnostics. His innovative compounds are set to improve the accuracy and effectiveness of tumor detection, showcasing the importance of research in the fight against cancer.